Search Results - "Franco, Vivian"
-
1
Treatment-related cardiotoxicity in survivors of childhood cancer
Published in Nature reviews. Clinical oncology (01-12-2013)“…Key Points Advances in treatment have increased the number of childhood cancer survivors with late-occurring, treatment-related cardiovascular complications…”
Get full text
Journal Article -
2
Cardioprotection and Safety of Dexrazoxane in Patients Treated for Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Advanced-Stage Lymphoblastic Non-Hodgkin Lymphoma: A Report of the Children's Oncology Group Randomized Trial Pediatric Oncology Group 9404
Published in Journal of clinical oncology (10-03-2016)“…To determine the oncologic efficacy, cardioprotective effectiveness, and safety of dexrazoxane added to chemotherapy that included a cumulative doxorubicin…”
Get full text
Journal Article -
3
Prevention of cardiotoxicity among survivors of childhood cancer
Published in British journal of clinical pharmacology (01-03-2017)“…Linked Articles This article is part of a joint Themed section with the British Journal of Pharmacology on Cardiotoxicity. The rest of the Themed section will…”
Get full text
Journal Article -
4
Cardiovascular Disease in Adult Survivors of Childhood Cancer
Published in Annual review of medicine (01-01-2015)“…Treatment advances have increased survival in children with cancer, but subclinical, progressive, irreversible, and sometimes fatal treatment-related…”
Get full text
Journal Article -
5
Anthracycline-Induced Cardiotoxicity: A Review of Pathophysiology, Diagnosis, and Treatment
Published in Current treatment options in cardiovascular medicine (01-06-2014)“…Opinion statement Anthracyclines have been widely used in children and adults to treat hematologic malignancies, soft-tissue sarcomas, and solid tumors…”
Get full text
Journal Article -
6
Cardiac complications in childhood cancer survivors treated with anthracyclines
Published in Cardiology in the young (01-08-2015)“…Cardiovascular complications are among the leading causes of morbidity and mortality among survivors of childhood cancer, after cancer relapse and secondary…”
Get more information
Journal Article -
7
Impact of hemochromatosis gene mutations on cardiac status in doxorubicin‐treated survivors of childhood high‐risk leukemia
Published in Cancer (01-10-2013)“…BACKGROUND Doxorubicin is associated with progressive cardiac dysfunction, possibly through the formation of doxorubicin‐iron complexes leading to free‐radical…”
Get full text
Journal Article -
8
Anthracycline-Associated Cardiotoxicity in Survivors of Childhood Cancer
Published in Pediatric cardiology (01-03-2011)“…Anthracycline chemotherapeutic agents are widely used to treat childhood cancers, helping to create an increasing population of childhood cancer survivors…”
Get full text
Journal Article -
9
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac Outcomes
Published in Pediatrics (Evanston) (01-12-2012)“…Doxorubicin, effective against many malignancies, is limited by cardiotoxicity. Continuous-infusion doxorubicin, compared with bolus-infusion, reduces early…”
Get full text
Journal Article -
10
Anthracycline-related cardiotoxicity in childhood cancer survivors
Published in Current opinion in cardiology (01-01-2014)“…PURPOSE OF REVIEWAnthracyclines have markedly improved the survival rates of children with cancer. However, anthracycline-related cardiotoxicity is also well…”
Get full text
Journal Article -
11
Cardiotoxicity in childhood cancer survivors: strategies for prevention and management
Published in Future cardiology (01-07-2012)“…Advances in cancer treatment have greatly improved survival rates of children with cancer. However, these same chemotherapeutic or radiologic treatments may…”
Get more information
Journal Article -
12
Impaired mitochondrial function is abrogated by dexrazoxane in doxorubicin‐treated childhood acute lymphoblastic leukemia survivors
Published in Cancer (15-03-2016)“…BACKGROUND Impaired cardiac function in doxorubicin‐treated childhood cancer survivors is partly mediated by the disruption of mitochondrial energy production…”
Get full text
Journal Article -
13
Effects of dexrazoxane on doxorubicin-related cardiotoxicity and second malignant neoplasms in children with osteosarcoma: a report from the Children's Oncology Group
Published in Cardio-oncology (London, England) (28-10-2019)“…Dexrazoxane protects from lower-cumulative-dose doxorubicin cardiotoxicity, but the effect of dexrazoxane in children with sarcoma treated with…”
Get full text
Journal Article -
14
An analysis of energy-drink toxicity in the National Poison Data System
Published in Clinical toxicology (Philadelphia, Pa.) (01-08-2013)“…Context. Small studies have associated energy drinks-beverages that typically contain high concentrations of caffeine and other stimulants-with serious adverse…”
Get full text
Journal Article -
15
An expert opinion on pharmacologic approaches to reducing the cardiotoxicity of childhood acute lymphoblastic leukemia therapies
Published in Expert opinion on pharmacotherapy (01-08-2013)“…Acute lymphoblastic leukemia (ALL) is the most common hematologic malignancy in children. Treatment-related cardiac damage is progressive and often difficult…”
Get more information
Journal Article -
16
Late Cardiotoxicity: Issues for Childhood Cancer Survivors
Published in Current treatment options in cardiovascular medicine (01-07-2016)“…Opinion statement Cardiovascular-related morbidity is a substantial health burden in survivors of childhood cancers. This burden is gaining importance as this…”
Get full text
Journal Article -
17
Changing recombinant factor VIII to plasma-derived factor VIII during immune tolerance induction
Published in Pediatric hematology and oncology (2024)Get full text
Journal Article -
18
Cardiotoxicity and cardioprotection in childhood cancer
Published in Acta haematologica (01-01-2014)“…Children diagnosed with cancer are now living longer as a result of advances in treatment. However, some commonly used anticancer drugs, although effective in…”
Get more information
Journal Article -
19
Prediction of the chance of successful immune tolerance induction in persons with severe hemophilia A and inhibitors: a clinical prediction model
Published in Research and practice in thrombosis and haemostasis (01-10-2024)“…Inhibitor eradication to restore factor (F)VIII efficacy is the treatment goal for persons with severe hemophilia A (HA) and inhibitors. Immune tolerance…”
Get full text
Journal Article -
20
Managing Chemotherapy-Related Cardiotoxicity in Survivors of Childhood Cancers
Published in Paediatric drugs (01-10-2014)“…In the US, children diagnosed with cancer are living longer, but not without consequences from the same drugs that cured their cancer. In these patients,…”
Get full text
Journal Article